What does this research mean for the field?

Liver enzymes, particularly GGT, are effective biomarkers for diagnosing non-fatal cardiovascular disease events. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

To examine the relationship between liver enzymes and non-fatal cardiovascular disease events through a systematic review.

March 2, 2026Open Access

The relationship between liver enzymes in the blood test and non-fatal cardiovascular disease events: a systematic review and meta-analysis

Key Points

To examine the relationship between liver enzymes and non-fatal cardiovascular disease events through a systematic review.
Conducted a systematic review of existing studies on liver enzymes and cardiovascular events.
Performed a meta-analysis to quantify the relationship between GGT levels and cardiovascular disease.
Evaluated diagnostic consistency across various studies.
Found a strong association between elevated GGT levels and incidence of cardiovascular diseases.
Results emphasize the potential of using liver enzymes as routine diagnostic tools.
Identified that GGT can serve as a reliable biomarker for cardiovascular risk assessment.

Abstract

There is a strong agreement on GGT for diagnosing cardiovascular diseases. These results can be applied as guidance for the diagnosis of cardiovascular diseases using liver enzymes as routine blood tests.

The relationship between liver enzymes in the blood test and non-fatal cardiovascular disease events: a systematic review and meta-analysis

Key Points

Abstract

Cite This Study

Also Consider

Also Consider